Huae Xu Selected Research

N-vinyl-2-pyrrolidinone

8/2016	Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line.
1/2015	Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo.
1/2014	An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huae Xu Research Topics

Disease

18	Neoplasms (Cancer) 07/2022 - 07/2009
7	Stomach Neoplasms (Stomach Cancer) 07/2021 - 02/2012
6	Lung Neoplasms (Lung Cancer) 06/2022 - 01/2014
3	Hypersensitivity (Allergy) 03/2020 - 06/2017
2	Reperfusion Injury 01/2020 - 05/2013
2	Glioma (Gliomas) 01/2017 - 04/2011
1	Breast Neoplasms (Breast Cancer) 07/2022
1	Hypoxia (Hypoxemia) 07/2022
1	Triple Negative Breast Neoplasms 07/2022
1	Sarcopenia 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Brain Edema (Cerebral Edema) 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Stroke (Strokes) 01/2020
1	Pneumonia (Pneumonitis) 07/2018
1	Infarction (Infarctions) 01/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018
1	Ischemia 01/2018
1	Adenocarcinoma of Lung 08/2016
1	Colorectal Neoplasms (Colorectal Cancer) 08/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016
1	Liver Neoplasms (Liver Cancer) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Carcinogenesis 02/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014
1	Melanoma (Melanoma, Malignant) 07/2009

Drug/Important Bio-Agent (IBA)

8	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 02/2012
5	Pharmaceutical PreparationsIBA 07/2021 - 04/2011
5	tetrandrineIBA 03/2020 - 02/2012
3	ResveratrolIBA 01/2020 - 05/2013
3	Nanoparticle Drug Delivery SystemIBA 01/2019 - 08/2016
3	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 01/2017 - 01/2016
3	caprolactoneIBA 08/2016 - 01/2014
3	N-vinyl-2-pyrrolidinoneIBA 08/2016 - 01/2014
2	Photosensitizing Agents (Photosensitizers)IBA 07/2022 - 04/2017
2	CurcuminIBA 06/2022 - 04/2011
2	SolventsIBA 03/2020 - 06/2017
2	AlkaloidsIBA 03/2020 - 01/2016
2	BenzylisoquinolinesIBA 03/2020 - 01/2016
2	AntioxidantsIBA 01/2020 - 05/2013
2	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2014
2	Ursolic AcidIBA 01/2015 - 01/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2014 - 01/2013
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 06/2022
1	triptolideIBA 07/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020
1	Succinic Acid (Succinate)IBA 03/2020
1	Peptides (Polypeptides)IBA 03/2020
1	aspartic acid glycine arginineIBA 03/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2018
1	AlbuminsIBA 01/2018
1	cremophor ELIBA 06/2017
1	Singlet OxygenIBA 04/2017
1	GoldIBA 04/2017
1	Drug CombinationsIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	Drug CarriersIBA 01/2016
1	HydrogelsIBA 01/2016
1	GelatinIBA 01/2016
1	Cysteine (L-Cysteine)FDA Link 01/2015
1	TriterpenesIBA 01/2015
1	deguelinIBA 01/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2014
1	Harmine (Telepathine)IBA 02/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Long Noncoding RNAIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 01/2014
1	polycaprolactoneIBA 04/2011
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2011
1	Docetaxel (Taxotere)FDA Link 07/2009

Therapy/Procedure

10	Therapeutics 06/2022 - 07/2009
3	Drug Therapy (Chemotherapy) 03/2020 - 01/2014
1	Photochemotherapy (Photodynamic Therapy) 07/2022
1	Molecular Targeted Therapy 07/2022
1	Photothermal Therapy 05/2022
1	Nephrectomy 01/2021
1	Immunotherapy 01/2020
1	Intra-Arterial Infusions 01/2020
1	Thrombectomy 01/2020
1	Precision Medicine 07/2018
1	Intravenous Injections 01/2018